1096920-35-2

Upstream product

• 1711-02-0 4-iodobenzoic acid chloride 
• 38769-92-5 4-methoxybenzylmagnesium chloride 
• 187617-01-2 N,O-Dimethyl-4-iodobenzenehydroxamic acid 

Downstream Products

• 1352547-04-6 3-(4-iodophenyl)-6-methoxy-2-(4-methoxyphenyl)-1H-indene 
• 1352547-05-7 1-(2-(4-(6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl)phenoxy)ethyl)pyrrolidine 
• 1352547-07-9 (R)-1-((S)-1-(4-(6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl)phenoxy)propan-2-yl)-3-methylpyrrolidine 
• 1352547-08-0 (3R)-1-((2S)-1-(4-(5-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1H-inden-1-yl)phenoxy)propan-2-yl)-3-methylpyrrolidine 
• 1352546-95-2 2-(4-hydroxyphenyl)-1-(4-((S)-2-((R)-3-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydro-1H-inden-5-ol 
• 1352547-01-3 1-(4-iodophenyl)-3-(3-methoxyphenyl)-2-(4-methoxyphenyl)propan-1-one 

Relevant academic research and scientific papers

Selective Metal-Free Deoxygenation of Unsymmetrical 1,2-Dicarbonyl Compounds by Chlorotrimethylsilane and Sodium Iodide

For the first time, the combination of chlorotrimethylsilane with NaI is used as a selective reducting system toward 1,2-diketones. This combination is successfully evaluated with several unsymmetrically benzil derivatives, which are reduced in good yield

INDANE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.